Epirubicin
Androgen Receptor Positive
City of Hope Medical CenterPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Androgen Receptor Positive cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide City of Hope Medical Center | Phase 2 | B |
Pembrolizumab City of Hope Medical Center | Phase 2 | B |
Enobosarm City of Hope Medical Center | Phase 2 | B |
Enzalutamide M.D. Anderson Cancer Center | Phase 1 | CC |
Alpelisib M.D. Anderson Cancer Center | Phase 1 | CC |
Same molecule, other indications
Epirubicin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →